Hopper Jonathan Mark 4
4 · Vericel Corp · Filed Dec 4, 2025
Insider Transaction Report
Form 4
Vericel CorpVCEL
Hopper Jonathan Mark
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2025-12-02$18.00/sh+1,652$29,736→ 68,214 total - Sale
Common Stock
2025-12-02$39.14/sh−1,652$64,659→ 66,562 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-12-02+1,652→ 7,098 totalExercise: $18.00Exp: 2030-02-11→ Common Stock (1,652 underlying)
Footnotes (3)
- [F1]These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2025.
- [F3]These options, representing the right to purchase 48,750 shares, became exercisable in quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 11, 2020.